Abrysvo 00069-2465
Generic: Respiratory Syncytial Virus Vaccine
Product NDC
00069-2465- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 30, 2024
- Listing Expires
- December 31, 2026
- Application
- BLA125769
Active Ingredients
| Ingredient | Strength |
|---|---|
| Recombinant Stabilized Rsv A Prefusion F Antigen | .06 mg/.5mL |
| Recombinant Stabilized Rsv B Prefusion F Antigen | .06 mg/.5mL |
Packaging Options(2)
1 VIAL in 1 CARTON (0069-2465-01) / .5 mL in 1 VIAL (0069-2465-19)
10 VIAL in 1 CARTON (0069-2465-10) / .5 mL in 1 VIAL (0069-2465-19)